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Lymphocytic cholangitis (LC) in cats is a biliary disease of unknown etiology. Helicobacter spp. were recently implicated in
human primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC). Because of the similarities between PSC/PBC with
LC, we hypothesized that Helicobacter spp. are involved in feline LC. A PCR with Helicobacter genus-specific 16S rRNA primers
was performed on DNA isolated from feline bile samples. Four of the 15 (26%) LC samples were positive, whereas only 8/51 (16%)
of non-LC samples were PCR positive (p ¼ 0:44). Sequence analysis of the amplicons revealed a 100% identity with the Helicobacter
pylori specific DNA fragments. Our data suggest an etiological role of H. pylori in feline LC and that cats are a potential zoonotic
reservoir.
 2004 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
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Cholangitis is a common biliary disease in cats. Based
on histological examination this inflammatory disease
can be classified into two distinct forms: (i) an acute or
chronic exudative cholangitis caused by an ascending
bacterial infection in which leucocytes predominate in
the lumen and wall of the bile ducts. Escherichia coli can
generally be cultured from the bile and the cats are
usually cured by standard antibiotic treatment, and (ii) a
chronic persistent cholangitis characterized by lympho-
cytic inflammation, subsequently referred to as lym-
phocytic cholangitis (LC). There are striking similarities
between LC and primary sclerosing cholangitis (PSC)* Corresponding author. Tel.: +31-30-2533943; fax: +31-30-2518126.
E-mail address: s.y.boomkens@vet.uu.nl (S.Y. Boomkens).
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doi:10.1016/j.femsim.2004.06.002and primary biliary cirrhosis (PBC) in humans with re-
spect to the chronic nature and the macroscopic and
microscopic lesions of the biliary system and the liver. In
the cat, the chronic inflammation of the biliary tree
causes an irregular severe dilatation of the extra- and
intrahepatic bile ducts. Histological examination of the
liver shows a consistent infiltration of small lymphocytes
in and restricted to the portal areas, often associated
with variable portal fibrosis and biliary ductular prolif-
eration. Lymphocytes centering around the bile ducts or
in the biliary epithelium may be present, but are not a
specific disease hallmark. In chronic cases bridging fi-
brosis between the portal areas may develop [1]. Bio-
chemical analysis of the blood of these cats reveals
increased bile salts, liver enzymes and often also mark-
edly increased gamma globulins. Signs of jaundice,
nausea, decreased appetite and gradual weight loss are
observed. Routine bile culture does not reveal a. Published by Elsevier B.V. All rights reserved.
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like PSC and PBC in man [2], it is assumed that the
disease has autoimmune or immune mediated features.
The classical treatment of feline LC consists of the ad-
ministration of immune suppressive drugs such as
prednisone, but this never results in cure of the disease.
The high level of gamma globulins in the blood of cats
with LC may be interpreted as a very chronic persistent
infection by a so far not identified virus or bacterium.
Moreover, standard antibiotic treatment as used for
exudative cholangitis in cats is not curative.
A potential candidate for a bacterial infection would
be Helicobacter species. Since the discovery of Helico-
bacter pylori as a major causative factor in the patho-
genesis of active chronic gastritis, and peptic ulcer
disease, more than 25 additional Helicobacter spp. have
been isolated from the stomach, intestinal tract and liver
of various mammalian and avian species. Several groups
have reported that Helicobacter DNA has been detected
in livers of humans with PSC, PBC [3–5] chronic cho-
lecystitis [6] and hepatocellular carcinomas (HCC) [7,8],
as well as in the livers of some animals with hepatitis,
such as mice, dogs and woodchucks [9–12].
Based on the similarities, feline LC may have a sim-
ilar etiology as PSC or PBC in humans. This prompted
us to test the association between a Helicobacter infec-
tion of the biliary tree and feline LC. Here, we describe
the detection of a DNA fragment typical for Helico-
bacter spp. in the bile of cats that is identical to a H.
pylori fragment found in humans with HCC. The pres-
ence of these Helicobacter-specific DNA fragments in
the bile of cats suggests that cats may be a potential
zoonotic hazard.2. Materials and methods
2.1. Feline bile samples
Bile samples were collected from 15 cats with his-
tologically confirmed LC that were presented to our
clinic for companion animals. Bile was aspirated under
sterile conditions with ultrasound guidance directly
from the gallbladder and was immediately snap-frozen
in liquid nitrogen and stored at )80 C until processing.
For comparison, 51 bile samples were also obtained
from cats with other liver diseases presented at our
clinic and at the pathology department; the bile of cats
presented at the latter department was collected at
necropsy. In addition, bile of two groups of clinically
healthy cats were included. These 12 cats were kept in
two closed colonies (one family of stray cats, n ¼ 5; and
one group of SPF control cats that were sacrificed at
the end of an unrelated study, n ¼ 7) and the livers of
these cats were histologically normal. All samples were
tested blind.2.2. Histological examination
At the time of bile collection from all cats also a liver
biopsy was obtained for histological examination.
Morphological classification of the biopsies was per-
formed by one experienced board-certified veterinary
pathologist (TSGAMvdI), who was blinded for the or-
igin of the samples. The sections were scored according
to the approach of the World Small Animal Veterinary
Association (WSAVA) Liver diseases and Pathology
Standardization Research Group [13].
2.3. DNA isolation
Approximately 1 ml of each bile sample was centri-
fuged at 14,000 rpm at 4 C for 10 minutes [14] The
supernatant was aspirated and stored at )20 C. DNA
was isolated from the pellet with the QIAamp DNA
mini kit (Qiagen, Hilden, Germany; tissue protocol)
according to the manufacturer’s instructions.The pellet
was lysed for 1.5 h at 56 C under continuous shaking
(150 rpm) with proteinase K. DNA was eluted in de-
ionized water and stored at )20 C.
2.4. PCR amplification
All PCRs were performed in a 50 ll volume with an
MJ Research thermal cycler (MJ Research Inc., Wa-
tertown, MA, USA) Reaction mixtures contained 0.2
lM of each oligonucleotide primer (Isogen Life Science,
Maarssen, The Netherlands), PCR buffer (Invitrogen
Corporation, Carlsbad, CA, USA), 2.5 U of Platinum
Taq polymerase (Invitrogen), 2 mM MgCl2(Invitrogen)
and 250 lM of each nucleotide. Primers HelicoF (50-
AAC GAT GAA GCT TCT AGC TTG CTA G-30) and
HelicoR (50-GTG CTT ATT CGT TAG ATA CCG
TCA T-30) based on the 16S rRNA sequences of most
gastric and enterohepatic members of the Helicobacter
genus were used to generate a 400-bp amplicon [7]. H.
pylori specific primers HP-ACT-1 (50-CTT GCT AGA
GTG CTG ATT A-3’) and HP-ACT-2 (5’-TCC CAC
ACT CTA GAA TAG T-30) [15] were used to generate a
539-bp product. For both the Helicobacter genus PCR
and the H. pylori PCR 5 ll of DNA was used in a first
reaction. The amplicons were diluted 10 times and 5 ll
of this dilution was used in a second reaction with the
same primers and the same conditions. The PCR con-
ditions were the following: an initial denaturation step
at 95 C for 4 min followed by a denaturation step for 30
s at 95 C, annealing at 50 C for 30 s, elongation at 72
C for 1 min. A total of 40 cycles was performed and
was followed by a final elongation step at 72 C for 10
min. As controls, chromosomal DNA of H. pylori strain
1061 [16] and a DNA sample isolated from canine liver
tissue that was positive in a PCR with the Helicobacter
genus primers were used. In order to exclude that PCR
Table 1
The number of cats included in this study with their histological di-
agnosis, the results of the PCR with primers HelicoF and HelicoR (400
bp) and the number of amplicons that were sequenced. All sequences
were confirmed to be Helicobacter specific DNA fragments homolo-
gous to the sequences reported by Avenaud et al. [7]
No. of cats Amplicon of
expected size
Sequencing
analysis
LC 15 4 2
Non-LC 51 8 3
Clinically
healthy
12 7 7
Total 78 19 12
Table 2
16S rRNA sequence differences in the 400 bp Helicobacter-specific
DNA fragments compared to the reference strain 26695 and to Heli-
cobacter-specific DNA sequences detected in liver tissue in other
studies
nt 91a nt 129a Reference
Helicobacter pylori reference
strain 26695 and other
H. pylori strains (n ¼ 12)
G T [17]
Verhoef et al. (n ¼ 9) A C [8]
Avenaud et al. (n ¼ 8) A C [7]
Magalheas Queiroz (n ¼ 1) A C [18]
Nilsson et al. (n ¼ 4) A C [4]
Cats with LC A C This study
Cats with other diseases A C This study
S.Y. Boomkens et al. / FEMS Immunology and Medical Microbiology 42 (2004) 307–311 309inhibition was the cause of negative PCRs, an additional
PCR was performed in which the negative samples were
spiked with different dilutions of Helicobacter DNA.
Several samples containing water were always used as
controls to exclude contamination.
2.5. Sequence analysis of the amplicons
The generated amplicons were directly sequenced
using primers HelicoF and HelicoR. Sequencing was
performed with an ABI 3100 genetic analyzer (Applied
Biosystems, Foster City, CA, USA). The resulting nu-
cleotide sequences were compared with the sequences
present in the GenBank databases using the BLAST
nucleotide program of the National Center for Bio-
technology Information (NCBI, www.ncbi.nlm.nih.-
gov\blast) and were aligned and analyzed using
Lasergene (DNAStar Inc. Madison, WI, USA) and
SECentral (Scientific & Educational Software, Durham,
NC, USA) software.
2.6. Statistical analyses
All statistical analyses were performed with the SPSS
11.0.1 Software (SPSS Inc. USA). Significance was tes-
ted by means of the Pearson v2 test. Differences were
regarded as significant if p < 0:05.Clinially healthy cats A C This study
A, adenine; C, cytosine; G, guanine; T, thymine.
aNumbering according to 16S rRNA of H. pylori strain 26695 [17].3. Results
3.1. PCR amplification with 16S rRNA primers
Of the 15 cats with LC, four cats were positive (26%)
in the PCR and generated a product of the expected size
of 400 bp. Of the bile samples of 51 cats with non-LC
liver diseases eight had a PCR fragment of the expected
size (24%). Of the 12 clinically healthy cats, seven were
positive (58%) in the PCR with PCR fragments of the
expected size. This is shown in Table 2. There was no
significant difference between the percentage of positive
cats in the PCR between the group of cats with LC and
the group of cats with other diseases (p ¼ 0:44).
3.2. Sequence analysis of the 16S rRNA amplicons
Sequence analysis of the PCR products of 12 Heli-
cobacter-genus PCR positive cats revealed that they
were all identical to the H. pylori-specific DNA sequence
that Avenaud et al. [7] detected in liver tissue of human
patients with HCC (deposited at GenBank; Accession
No. AF 142585; H. pylori ‘‘liver 3’’) for all samples
tested, as indicated in Table 1. We were unable to se-
quence the other fragments obtained in this study, be-
cause of their low yield. In addition, on four positive
samples in the Helicobacter genus PCR of which we hadenough material and four negative samples in this PCR
we performed an additional PCR with H. pylori specific
primers. The four genus PCR positive samples were all
positive in the H. pylori specific PCR, whereas the four
negative samples in the genus PCR were also negative in
the H. pylori specific PCR.
Our H. pylori-like 16S rRNA sequences and the
identical sequences (H. pylori ‘‘liver 3’’) found in the
database all differed at two base pair positions in the 400
bp PCR fragment when compared to the sequenced H.
pylori reference strain 26695 [17]. These differences were
at positions 91 (G to A) and 129 (T to C), respectively,
of the 16S rRNA gene sequence ofH. pylori strain 26695
(Table 2). Our positive control did not have these typical
basepair differences, which excludes contamination of
the samples with the DNA of the positive control.4. Discussion
In this study, H. pylori-specific DNA fragments were
detected by PCR analysis in the bile of 26% of cats di-
agnosed with LC. Based on the homology of these 16S
rRNA gene products, they are most likely derived from
members of the Helicobacter genus. A somewhat lower
310 S.Y. Boomkens et al. / FEMS Immunology and Medical Microbiology 42 (2004) 307–311number of cats (16%) with other liver diseases were
positive in this PCR. All amplicons of which enough
material could be obtained for sequence analysis were
identical to H. pylori DNA fragments that were identi-
fied in the liver of humans with hepatocellular carci-
noma [7], which have 2 base pairs difference with the H.
pylori reference strain 26695. This indicates that they
form separate clusters of Helicobacters, as all sequences
differed two base pair positions with the conserved 400
base pairs part of the 16S rRNA gene of the H. pylori
reference strains. These two typical base pair differences
were also absent from 16S rRNA gene of other gastric
Helicobacters, such as H. felis, H. bizzozeroni, H. salo-
monis and H. heilmannii, or any of the sequenced 16S
rRNA sequences of enterohepatic Helicobacter species.
Strikingly, these two mutations have thus far only been
found in Helicobacter-specific sequences detected in liver
tissue of human patients with different liver diseases,
such as HCC, PSC and PBC (Table 2). Since we do not
have the sequence data of all PCR fragments (only 12/19
could be sequenced), we cannot be 100% sure that all
fragments have these mutations. In addition, all samples
that were subjected to a H. pylori specific PCR were also
positive in this test, indicating that we indeed detected
H. pylori specific DNA fragments in the bile of these
cats.
To our knowledge, this is the first description of the
detection of H. pylori-specific DNA fragments from bile
of cats. Over the past years, many groups have described
the amplification of Helicobacter-specific DNA in the
intestines, bile and liver of various mammals. However,
efforts to culture Helicobacters from these samples were
mostly unsuccessful. In this study, limited cultivation
efforts failed to demonstrate growth of Helicobacter-like
organisms on both selective and non-selective media.
The only published successful attempt to culture H.
pylori-like bacteria in bile and liver samples is from a
liver biopsy sample of a patient with Wilson’s disease
[18], who also harbored H. pylori in the stomach.
Therefore, it was suggested that the organism most
likely colonized the already diseased liver as a secondary
event and that the hepatic abnormality was necessary
for colonization. In our study some cats that were po-
sitive in the Helicobacter genus PCR were severely ill
and therefore likely immuno-compromised, thus gener-
ating the option for Helicobacters to colonize these
hosts a as secondary event. In a recent report [8] a
Helicobacter specific DNA fragment with the exact same
sequence as observed by Avenaud [7] and in this study,
was found in both liver and gastric specimens of patients
with non-cirrhotic HCC. Unfortunately it was not pos-
sible to collect gastric specimens of our cats, thus it was
not possible to test for the presence of gastric Helico-
bacter-specific fragments, which are very common in
cats, in order to see whether these would be identical to
those found in the bile.The clinically healthy cats had a remarkably high
fraction of positive samples. Their PCR products had
exactly the same typical basepairs differences that were
also present in the PCR fragments of the diseased cats in
this study. These healthy cats originated from two col-
onies in which they were kept in close association. The
high incidence in these groups indicates transmission
and subsequent colonization of the bacterium between
members of the groups. This would indicate that the
Helicobacters found in the cats in this study are indeed
potentially transmittable pathogens. Consequently, this
does not allow the comparison of LC plus non-LC cats
with healthy cats.
Although no significant difference in prevalence
between the LC and non-LC cats (p ¼ 0:44, v2 test), it
may be an indication that there is indeed an etiolog-
ical association between the presence of Helicobacter
specific DNA sequences and LC in cats. For definite
proof, however, studies in much larger series will be
required. Moreover, in a pilot study a treatment
consisting of direct injection into the gallbladder of
antibiotics aimed at H. pylori eradication (i.e. amoxi-
cillin, gentamycin and metronidazole) has been applied
to three cats in our clinic, thus far with a good clinical
response. Recently, Nilsson et al. [4] identified H.
pylori specific sequences in liver samples of patients
with PSC and PBC (Table 2). The H. pylori DNA
sequences found in liver of patients with PSC and
PBC have identical sequence characteristics as the H.
pylori specific DNA fragments detected in the bile of
cats. Moreover, there are more assumptions that PSC
and PBC are of infectious origin or that the bacterium
may trigger an autoimmune response [2,5]. This may
also be the case in feline LC.
The knowledge that gastric Helicobacters may be
present in the stomach without causing any clinical
symptoms was long thought to indicate that these He-
licobacters are opportunistic pathogens. It cannot be
excluded that the H. pylori-specific sequences observed
in this study represent such opportunistic pathogens and
possible zoonoses, like H. heilmannii [19]. In the light of
our current knowledge, and given that Handt et al. [20]
detected H. pylori in the stomach of cats, it may well be
possible that (i) H. pylori is the causative agent of feline
LC, and (ii) cats represent a reservoir for this bacterium.
To our knowledge this is the first report on the presence
of H. pylori DNA sequences in the bile of a significant
proportion of individuals from a non-human species.
The presence of these DNA sequences in the bile of cats
suggests that cats may be a potential zoonotic hazard.Acknowledgements
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